NeuroMetrix, Inc., a healthcare company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, China, the Middle East, and Mexico. Its primary marketed products include DPNCheck, a nerve conduction test that is used to evaluate peripheral neuropathies, such as diabetic peripheral neuropathy; Quell, a wearable device for symptomatic relief and management of chronic pain; and ADVANCE system, a platform for the performance of nerve conduction studies. The company offers its products to managed care organizations, endocrinologists, podiatrists, and primary care physicians; occupational health, primary care, internal medicine, orthopedic, and hand surgeons; and pain medicine physicians, neurologists, physical medicine and rehabilitation physicians, and neurosurgeons. NeuroMetrix, Inc. was incorporated in 1996 and is headquartered in Woburn, Massachusetts.
NeuroMetrix Dividend Announcement
• NeuroMetrix announced a annually dividend of $0.15 per ordinary share which will be made payable on 2007-04-13. Ex dividend date: 2007-03-28
• NeuroMetrix's trailing twelve-month (TTM) dividend yield is -%
NeuroMetrix Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2007-03-28 | $0.15 | annually | 2007-04-13 |
NeuroMetrix Dividend per year
NeuroMetrix Dividend Yield
NeuroMetrix current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing NeuroMetrix stock? Use our calculator to estimate your expected dividend yield:
NeuroMetrix Financial Ratios
NeuroMetrix Dividend FAQ
1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.
2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.
3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.
4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.
5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Place an order: Use the brokerage's trading platform to place an order to buy NeuroMetrix stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.